Lilly: WeightWatchers Integrates With Eli Lilly To Expand Access To Zepbound, Stock Skyrockets 110%

WW International Inc (NASDAQ:WW) shares are trading higher by 110% to 87 cents during Tuesday's session after the company announced a new partnership with Eli Lilly's LillyDirect pharmacy provider, Gifthealth, to simplify access to the popular weight loss drug Zepbound for its clinic members.What To Know: WeightWatchers says this integration allows eligible self-pay patients, without insurance coverage, to receive prescriptions for Zepbound in single-dose vial form directly through the WeightWatchers app, which now includes real-time tracking and a streamlined fulfillment process.Per WeightWatchers, Zepbound usage has surged among WeightWatchers Clinic members, with prescriptions for the vial ...Full story available on Benzinga.com